To ensure absolute reproducibility in preclinical research, PX1 Research Subjects every batch of synthetic peptides to rigorous analytical validation. For researchers evaluating synthetic heptapeptides like Selank, full-spectrum analytical verification provides the exact purity, identity, and bioburden metrics necessary for controlled laboratory assays. This article details the complete analytical testing stack applied to every lot of Selank before distribution.
To ensure absolute reproducibility in preclinical research, PX1 Research Subjects every batch of synthetic peptides to rigorous analytical validation. For researchers evaluating synthetic heptapeptides like Selank, full-spectrum analytical verification provides the exact purity, identity, and bioburden metrics necessary for controlled laboratory assays. This article details the complete analytical testing stack applied to every lot of Selank before distribution.
Synthetic peptide manufacturing via Solid-Phase Peptide Synthesis (SPPS) inherently risks generating structural variants, truncated sequences, and organic impurities. When ordering compounds for in vitro or animal models, investigators require complete transparency regarding chemical identity and purity. A batch that lacks comprehensive testing can introduce unquantified variables, compromising enzymatic, receptor-binding, or gene-expression assays.
PX1 Research enforces strict quality control standards for every production batch. Operating out of USA-based, GMP-compliant facilities, PX1 utilizes ISO 17025 accredited third-party laboratories to perform independent analytical verification. Every single batch of selank third party tested material undergoes quantitative and qualitative screening to verify that the sequence matches structural models and meets demanding target specs prior to lyophilization and final packaging.
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary quantitative assay for determining peptide purity. In this method, the sample is dissolved in an appropriate mobile phase and injected onto a C18 hydrophobic stationary phase column. A linear gradient of acetonitrile containing trifluoroacetic acid (TFA) as an ion-pairing agent is applied to separate the parent peptide from synthetic side-products, diastereomers, and deleted sequences.
The resulting chromatogram measures UV absorbance—typically at 214 nm, corresponding to the peptide backbone absorption. Purity is calculated via area percent integration of the primary peak relative to all detected impurity peaks. PX1 mandates that every lot of Selank 10mg achieves a minimum purity of 98.0% by HPLC area integration. Chromatograms displaying target peak retention times, baseline separation, and integration tables are generated directly by the testing lab and attached to the lot documentation.
While RP-HPLC establishes chemical purity, it does not definitively confirm molecular structure. Mass Spectrometry—specifically Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF)—is executed concurrently to verify the molecular weight of the synthetic peptide.
Selank is a heptapeptide with the primary amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (molecular formula C33H57N11O9). The calculated monoisotopic mass is approximately 751.43 Da. During ESI-MS analysis, the observed mass-to-charge ratio (m/z) spectrum is evaluated for the single-charged [M+H]+ and double-charged [M+2H]2+ ions. An exact match between the experimentally determined molecular mass and the theoretical molecular mass confirms the exact chemical identity of the peptide, ruling out sequence inversion or improper amino acid coupling during synthesis.
A common point of confusion in laboratory research is the distinction between gross lyophilized cake weight and net peptide content. Lyophilized peptide preparations naturally retain counterions (such as acetate or trifluoroacetate from purification) and residual trace moisture. Consequently, a 10 mg vial of lyophilized material does not consist of 100% pure peptide weight.
To determine the actual concentration of active peptide for precise assay dosing, PX1 assesses net peptide content using elemental Nitrogen Analysis (CHN analysis) or UV spectrophotometric quantification. By determining the exact ratio of active peptide to total cake weight, researchers can accurately calculate stock solution concentrations. Understanding these parameters allows investigators to browse our catalog of research peptides with complete confidence in their molar calculations.
Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant risk in cell culture and preclinical research. Exposure to endotoxins can trigger unwanted inflammatory cascades, alter receptor expression, and invalidate experimental biological models.
Every production lot at PX1 undergoes rigorous bioburden and endotoxin testing using the chromogenic Limulus Amebocyte Lysate (LAL) assay. Tested against USP guidelines, every lot of Selank must demonstrate endotoxin levels below 0.05 EU/mg. Furthermore, fill-finish procedures are conducted inside ISO Class 5 cleanrooms to ensure sterile filtration (0.22-micron) prior to lyophilization, preventing microbial contamination in the finished vial.
Traceability is essential for maintaining experimental integrity across multi-phase studies. Every vial shipped by PX1 features a dedicated lot number printed directly on the label. This lot number directly correlates to an individual batch manufacturing record and its corresponding third-party Certificate of Analysis (COA).
To verify a batch, researchers can access our centralized COA lookup database. The COA displays raw HPLC chromatograms, mass spec peak charts, LAL assay results, and the official signature of the QA/QC director. Matching the lot number on your physical vial to the digital analytical document ensures that the compound in your laboratory matches the precise physical-chemical specifications published by our testing facility.
Selank belongs to a specific class of synthetic regulatory peptides derived from endogenous immunomodulatory sequences. When designing comparative in vitro or animal studies, researchers frequently evaluate related synthetic compounds within the same functional family.
Analytical protocols applied to Selank are equally deployed across similar compounds in our library. For instance, Semax undergoes identical RP-HPLC and ESI-MS validation to confirm its heptapeptide structure (Met-Glu-His-Phe-Pro-Gly-Pro). Similarly, modified variants such as N-Acetyl Selank Amidate require modified HPLC gradient profiles due to acetyl and amide terminal capping, which alter lipophilicity and column retention times. Comparative studies utilizing these peptides depend on uniform analytical testing protocols across all compounds to isolate sequence-specific biological effects.
PX1 maintains a strict retained sample policy for every manufactured batch. Aliquots from each lot are stored in temperature-monitored archives at -20°C and -80°C to allow for retrospective analysis, long-term degradation tracking, and stability testing.
Preclinical stability studies indicate that lyophilized synthetic heptapeptides remain stable when stored desiccated at -20°C, protected from light exposure. Avoid repeated freeze-thaw cycles of reconstituted liquid solutions, as ice crystal formation can promote peptide chain aggregation or cleavage. Detailed analytical stability data for archival samples can be reviewed within our technical research hub.
Proper reconstitution technique is critical to preserve peptide integrity once analytical purity has been verified. Lyophilized cakes should be brought to room temperature prior to solvent addition to prevent moisture condensation inside the vial.
Laboratory researchers typically reconstitute synthetic peptides using Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on assay compatibility. Solvents should be gently trickled down the glass wall of the vial rather than sprayed directly onto the peptide cake. Gentle swirl mixing—never vigorous vortexing—is recommended to prevent mechanical shearing of the peptide chain. To calculate precise solvent volumes and final molar concentrations for laboratory assays, utilize our interactive reconstitution calculator. Institutional buyers requiring bulk quantities for large-scale studies can also submit inquiries via our wholesale portal.
What testing methods are used to confirm Selank identity and purity?
PX1 utilizes Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity quantification (>98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm molecular weight and structural identity.
What is the maximum endotoxin threshold for PX1 Selank lots?
All Selank lots are tested via chromogenic LAL assays to ensure endotoxin levels remain strictly below 0.05 EU/mg, minimizing background interference in sensitive biological research.
How do I match my vial to the correct Certificate of Analysis (COA)?
Locate the lot number printed on the vial label and enter it into the PX1 online COA lookup tool to instantly download the raw HPLC chromatograms, MS spectra, and testing results for that exact batch.
What is the difference between peptide purity and net peptide content?
Peptide purity (RP-HPLC area %) measures the ratio of target peptide to synthetic peptide impurities. Net peptide content measures the actual weight percentage of pure peptide relative to residual moisture and counterions in the lyophilized cake.
Are PX1 research peptides manufactured in GMP facilities?
Yes. All PX1 compounds are synthesized in state-of-the-art USA facilities operating under GMP compliance guidelines and verified by independent ISO 17025 accredited analytical laboratories.
How should reconstituted Selank be stored in the laboratory?
Reconstituted peptide solutions should be stored at 2°C to 8°C for short-term experimentation or aliquoted and stored at -20°C to -80°C for extended research. Repeated freeze-thaw cycles must be avoided.
Can Selank be ordered in bulk for institutional research accounts?
Yes. Institutional laboratories and academic facilities conducting large-scale preclinical trials can request bulk lot quotes and customized batch analytics directly through our wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.